Alpha-interferon therapy for lymphoproliferative disorders developing in two children following bone marrow transplants

J Biol Response Mod. 1989 Dec;8(6):603-13.

Abstract

Two children developed lymphoproliferative processes following marrow transplantation. One of the two lymphoproliferative processes was documented to be Epstein-Barr virus (EBV)-associated. Both children received an extended course of alpha-interferon and gammaglobulin and responded with the disappearance of the lymphoproliferative process. Side effects from the alpha-interferon were minimal. Previous experience with EBV-associated lymphoproliferative processes following marrow transplantation have been usually fatal. This report further substantiates that alpha-interferon has a role in the treatment of EBV-associated lymphoproliferative processes following marrow transplantation.

Publication types

  • Case Reports

MeSH terms

  • Anemia, Aplastic / surgery
  • Bone Marrow Transplantation / adverse effects*
  • Child
  • Child, Preschool
  • Female
  • Graft vs Host Disease / prevention & control
  • Herpesvirus 4, Human
  • Humans
  • Interferon Type I / therapeutic use*
  • Lymphoproliferative Disorders / etiology
  • Lymphoproliferative Disorders / therapy*
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / surgery
  • Tumor Virus Infections / complications
  • Tumor Virus Infections / therapy
  • gamma-Globulins / therapeutic use

Substances

  • Interferon Type I
  • gamma-Globulins